Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson pharmaceuticals ltd. - primaquine - tablet - 15 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - primaquine - tablet - 15 mg

Canada - English - Health Canada

mylan pharmaceuticals ulc - clindamycin (clindamycin phosphate) - solution - 150mg - clindamycin (clindamycin phosphate) 150mg - lincomycins

Canada - English - Health Canada

taro pharmaceuticals inc - clindamycin (clindamycin phosphate) - solution - 1% - clindamycin (clindamycin phosphate) 1% - antibiotics

Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - chloroquine phosphate - tablets - 250 milligram

Singapore - English - HSA (Health Sciences Authority)

beacons pharmaceuticals pte. ltd. - chloroquine phosphate - tablet, film coated - 250 mg - chloroquine phosphate 250 mg